Objectives To use data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) to estimate mortality and disability trends for the population aged ≥70 and evaluate patterns in causes of […]
Background Supplier-induced demand (SID) refers to the concept that healthcare providers may deliver services that are not medically necessary to patients. An estimation of the extent to which this event has occurred can be insightful […]
Background Clinical Practice Guidelines (CPGs) can be adapted to local conditions to prevent any resources from being wasted. Adaptation of CPGs implies a systematic view of developed guidelines through maintaining evidence-based principles in order to […]
Background Iran considers the revision of its health insurance benefit package (HIBP) as a means to achieve universal health coverage (UHC). Yet, its decision-making process has been criticised for being weak in terms of accountability […]
Objective To review the research dimensions of trauma registry data on health policy making. Methods PubMed and EMBASE were searched until July 2020. Keywords were used on the search process included Trauma, Injury, Registry and […]
Objectives This study aimed to identify different criteria for priority setting of rare diseases to help policy makers in making evidence-informed decisions. Methods A scoping review was conducted to comprehensively examine the existing various methods […]
Background A significant proportion of cardiovascular disease (CVD) morbidity and mortality could be prevented via the population-based and cost-effective interventions. A fixed-dose combination treatment is known as the polypill for the primary and secondary prevention […]
Background Measuring the efficiency and productivity of hospitals is a key tool to cost contamination and management that is very important for any healthcare system for having an efficient system. Objective The purpose of this […]
Abstract As we are becoming more resilient to the catastrophic burden of the COVID-19 pandemic, the threat of future outbreaks is still on the horizon. Since detecting the first COVID-19 case in Iran (19 February […]
Abstract Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicates that HPV vaccination is not cost-effective in Iran. Using cost-effectiveness analysis for decision-making about […]